micro-community-banner
  • Saved

1yr
Meal timing and its role in obesity and associated diseases

Meal timing and its role in obesity and associated diseases

Source : https://pubmed.ncbi.nlm.nih.gov/38586455/

Meal timing emerges as a crucial factor influencing metabolic health that can be explained by the tight interaction between the endogenous circadian clock and metabolic homeostasis. Mistimed food intake, such...

Optimizing meal timing by aligning with circadian rhythms can enhance metabolic health and prevent obesity-related diseases. Future interventions should consider individual chronotype and external factors for effective lifestyle modifications.

  • Saved

1yr
Drug approach to treatment for obesity in adults: perspectives and considerations

Drug approach to treatment for obesity in adults: perspectives and considerations

Source : https://pubmed.ncbi.nlm.nih.gov/38345504/

Obesity is considered a chronic disease and a serious public-health issue in Spain, as well as in many other countries, primarily because of it being a significant risk factor for...

Obesity is a chronic disease and major public health issue in Spain, significantly increasing risk for multiple chronic conditions and cancers, with weight loss improving health outcomes.

  • Saved

1yr
Physiopathology and Treatment of Obesity and Overweight: A Proposal for a New Anorectic

Physiopathology and Treatment of Obesity and Overweight: A Proposal for a New Anorectic

Source : https://pubmed.ncbi.nlm.nih.gov/38566891/

The "new epidemic," as WHO calls obesity, is caused by overeating, which, having exceeded the body's actual needs, accumulates in the form of health-damaging fat deposits. Moving more and eating...

The article examines obesity, its causes, compulsive forms like food addiction, and explores pharmacological treatments, including a new anorectic, for managing compulsive obesity.

  • Saved

1yr
Major Advances in Diabetes Research and Treatment Unveiled at ADA Scientific Sessions

Dr. Robert Gabbay, Chief Scientific and Medical Officer of the American Diabetes Association, highlights key themes from this year’s ADA Scientific Sessions, including significant progress in obesity treatment, type 1 diabetes, technology, health disparities, and innovation. Notable studies, such as the FLOW trial on GLP-1 receptor agonists for kidney outcomes and the Surmount OSA study on sleep apnea, were discussed.

Dr. John Buse shared insights from the Catalyst Study, revealing a high prevalence of hypercortisolism in patients with difficult-to-control type 2 diabetes, potentially reshaping future screening and treatment guidelines.

  • 1yr
    Fascinating studies and gives us another armament to control DM, HTN ASVD , CKD hopefully in the near future thanks
  • Saved

1yr
Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options

Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options

Source : https://pubmed.ncbi.nlm.nih.gov/38156451/

Atrial fibrillation (AF) is the most common cardiac arrhythmia. AF increases the risk of stroke, heart failure, dementia, and hospitalization. Obesity significantly increases AF risk, both directly and indirectly, through...

Obesity drives atrial fibrillation through multiple mechanisms, worsening outcomes and impacting treatment efficacy. Weight loss improves AF risk and recurrence, highlighting the need for personalized management strategies.